Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · July 16, 2015

Irinotecan Drug-Eluting Beads With Simultaneous FOLFOX Improves Outcomes of Patients With Colorectal Liver Metastases

Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Cancer
Randomized Controlled Trial of Irinotecan Drug-Eluting Beads With Simultaneous FOLFOX and Bevacizumab for Patients With Unresectable Colorectal Liver-Limited Metastasis
Cancer 2015 Jul 06;[EPub Ahead of Print], RC Martin, CR Scoggins, M Schreeder, WS Rilling, CJ Laing, CM Tatum, LR Kelly, RD Garcia-Monaco, VR Sharma, TS Crocenzi, SM Strasberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading